Ipsen

Ipsen is a France-based biopharmaceutical company that develops and commercializes generic medicines for the treatment of cancer and neurogenerative disease.

Business Model:

Revenue: $2.9B

Employees: 5,001-10,000

Detailed Ipsen Information

Ipsen was acquired by Ipsen.
The acquisition happend on 2019-02-25.
Details of the transaction were not public

Acquirer

Geographic Data

Ipsen headquarters map

Address: 65 Quai Georges Gorse

City: Boulogne-Billancourt

State: other

Zip: 92100

Country: FR

Financial Info

Stage:

series unknown

Raised Last:

$60M

Raised Total:

$93M

Metrics

0Website Global Rank

0Website Monthly Traffic

Twitter Followers

Description

Ipsen is a France-based biopharmaceutical company that develops and commercializes generic medicines for the treatment of cancer and neurogenerative disease.

Contact Phone:

Contact Email:

Ipsen went public on 8/22/2017 on the PA

Listed Exchange:
PA

IPO Date:
8/22/2017

IPO Valuation:
$457M

Ticker Symbol:
IPN

IPO Price:
$15/share

Amount Raised:
$147M

Live

Opened: -/share

EBITDA -
Total Cash -
Total Debt -
Total Revenue -
Total Profit (Gross) -
PE Ratio -
Announced Date Company Transaction Money Raised
Uniview Singapore VEID Logo
Uniview Singapore VEID
Revenue: 0 - 100000
Employees:
Industry: Software
Details
Konkuk University Medical Center Logo
Konkuk University Medical Center
Revenue: 0 - 100000
Employees: 51 - 500
Industry: Education
Details
Daemon Technologies Logo
Daemon Technologies
Revenue: 0 - 100000
Employees: 1 - 10
Industry: Blockchain
Details
Ace International Trade Logo
Ace International Trade
Revenue: 0 - 100000
Employees: 11 - 50
Industry: Industrial
Details
An Hòa Communications Logo
An Hòa Communications
Revenue: 0 - 100000
Employees: 1 - 10
Industry: Advertising
Details

You know, we could be doing all this for you..

CoBee's Logo

Be ahead of your competition

  • Realtime intelligence
  • Automated contact tracking
  • Unmatched insights
  • Eliminate manual research